Cancer Policy: Pharmaceutical Safety

• Corporate Author: SpringerLink (Online service)
• Other Authors: McKoy, June M. (Editor, http://id.loc.gov/vocabulary/relators/edt), West, Dennis P. (Editor, http://id.loc.gov/vocabulary/relators/edt)
• Format: Electronic eBook
• Language: English
• Published: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Edition: 1st ed. 2019.
• Series: Cancer Treatment and Research, 171
• Subjects: Oncology .; Pharmacy.; Oncology.; Drug Safety and Pharmacovigilance.

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chap...

Table of Contents:

• Pharmacovigilance programs: Do they improve Cancer Drug Safety?
• Impact of Cost on the Safety of Cancer pharmaceuticals
• Assessing pharmaceutical safety in Geriatric Oncology
• Cancer co-Morbidity: Implications for Drug Safety
• Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?
• Pharmacovigilance of alternative medications in the Cancer Setting
• Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology
• Biosimilars: Are they really safe?
• Natural Language processing: improving the identification and communication of Cancer Drug Safety
• The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety
• Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
• Cancer Drug Toxicity: Moving from patient to Survivor.